165 related articles for article (PubMed ID: 12450707)
1. Cost-effectiveness of hepatitis B vaccination of prison inmates.
Pisu M; Meltzer MI; Lyerla R
Vaccine; 2002 Dec; 21(3-4):312-21. PubMed ID: 12450707
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Jacobs RJ; Rosenthal P; Meyerhoff AS
Vaccine; 2004 Mar; 22(9-10):1241-8. PubMed ID: 15003653
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of HIV counseling and testing in US prisons.
Varghese B; Peterman TA
J Urban Health; 2001 Jun; 78(2):304-12. PubMed ID: 11419583
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
[TBL] [Abstract][Full Text] [Related]
5. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
Krahn M; Detsky AS
Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
[TBL] [Abstract][Full Text] [Related]
6. [Economic evaluation on strategy for preventing mother-to-child transmission of hepatitis B in Zhejiang Province].
Zeng YB; Luo ML; He HQ; Deng X; Xie SY; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):706-712. PubMed ID: 31288342
[No Abstract] [Full Text] [Related]
7. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
8. Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program.
Krahn M; Guasparini R; Sherman M; Detsky AS
Am J Public Health; 1998 Nov; 88(11):1638-44. PubMed ID: 9807529
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
11. [Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis].
Zhang SX
Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May; 26(3):154-8. PubMed ID: 1395956
[TBL] [Abstract][Full Text] [Related]
12. Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits.
Boccalini S; Taddei C; Ceccherini V; Bechini A; Levi M; Bartolozzi D; Bonanni P
Hum Vaccin Immunother; 2013 May; 9(5):1119-28. PubMed ID: 23376840
[TBL] [Abstract][Full Text] [Related]
13. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
[TBL] [Abstract][Full Text] [Related]
14. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
15. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.
Rafia R; Dodd PJ; Brennan A; Meier PS; Hope VD; Ncube F; Byford S; Tie H; Metrebian N; Hellier J; Weaver T; Strang J
Addiction; 2016 Sep; 111(9):1616-27. PubMed ID: 26990598
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of economic outcomes of "hepatitis B vaccine event reported by media" in China, 2013].
Zhang SX; Sun PP; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):837-841. PubMed ID: 30107719
[No Abstract] [Full Text] [Related]
17. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
[TBL] [Abstract][Full Text] [Related]
19. Using gross national product to calculate acceptable immunisation costs: deploying cost-effectiveness calculations in reverse.
Tyagi V; Singh SK; Sawhney A; Taneja V; Puliyel JM
Pharmacoeconomics; 2003; 21(7):497-9. PubMed ID: 12696989
[No Abstract] [Full Text] [Related]
20. Economic evaluation of universal newborn hepatitis B vaccination in China.
Lu SQ; McGhee SM; Xie X; Cheng J; Fielding R
Vaccine; 2013 Apr; 31(14):1864-9. PubMed ID: 23384752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
